Local Neuroinflammation and the Progression of Alzheimer's Disease

Postmortem immunohistochemical studies have revealed a state of chronic inflammation limited to lesioned areas of brain in Alzheimer's disease. Some key actors in this inflammation are activated microglia (brain macrophages), proteins of the classical complement cascade, the pentraxins, cytokin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurovirology 2002-12, Vol.8 (6), p.529-538
Hauptverfasser: McGeer, Patrick L, McGeer, Edith G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 538
container_issue 6
container_start_page 529
container_title Journal of neurovirology
container_volume 8
creator McGeer, Patrick L
McGeer, Edith G
description Postmortem immunohistochemical studies have revealed a state of chronic inflammation limited to lesioned areas of brain in Alzheimer's disease. Some key actors in this inflammation are activated microglia (brain macrophages), proteins of the classical complement cascade, the pentraxins, cytokines, and chemokines. The inflammation does not involve the adaptive immune system or peripheral organs, but is rather due to the phylogenetically much older innate immune system, which appears to operate in most tissues of the body. Chronic inflammation can damage host tissue and the brain may be particularly vulnerable because of the postmitotic nature of neurons. Many of the inflammatory mediators have been shown to be locally produced and selectively elevated in affected regions of Alzheimer's brain. Moreover, studies of tissue in such degenerative processes as atherosclerosis and infarcted heart suggest a similar local innate immune reaction may be important in such conditions. Much epidemiological and limited clinical evidence suggests that nonsteroidal anti-inflammatory drugs may impede the onset and slow the progression of Alzheimer's disease. But these drugs strike at the periphery of the inflammatory reaction. Much better results might be obtained if drugs were found that could inhibit the activation of microglia or the complement system in brain, and combinations of drugs aimed at different inflammatory targets might be much more effective than single agents.
doi_str_mv 10.1080/13550280290100969
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72768197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18656126</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-9e43208929270d6335ce9ac1fd608e2235509d59c6b098a01a081c4b265c1b4c3</originalsourceid><addsrcrecordid>eNqFkD1PwzAQhi0EolD4ASwoE0yB80ccW0ylfEoVMMAcOc6FpEriYicD_HpStRIDEkx3unvule4h5ITCBQUFl5QnCTAFTAMF0FLvkAOacBUzIfju2I_7eATEhByGsASgXDK1TyaUiVRykR6Q64WzpomecPCu7srGtK3pa9dFpiuivsLoxbt3jyGsZ66MZs1XhXWL_jxEN3VAE_CI7JWmCXi8rVPydnf7On-IF8_3j_PZIraC8T7WKDgDpZlmKRSS88SiNpaWhQSFjK1_0UWircxBKwPUgKJW5EwmlubC8ik52-SuvPsYMPRZWweLTWM6dEPIUpZKRXX6L0iVTCRlcgTpBrTeheCxzFa-bo3_zChka8PZL8Pjzek2fMhbLH4utkpH4GoDjDqdb02FpukrazxmSzf4blT0R_w35WmGdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18656126</pqid></control><display><type>article</type><title>Local Neuroinflammation and the Progression of Alzheimer's Disease</title><source>MEDLINE</source><source>Access via Taylor &amp; Francis</source><source>SpringerLink Journals - AutoHoldings</source><creator>McGeer, Patrick L ; McGeer, Edith G</creator><creatorcontrib>McGeer, Patrick L ; McGeer, Edith G</creatorcontrib><description>Postmortem immunohistochemical studies have revealed a state of chronic inflammation limited to lesioned areas of brain in Alzheimer's disease. Some key actors in this inflammation are activated microglia (brain macrophages), proteins of the classical complement cascade, the pentraxins, cytokines, and chemokines. The inflammation does not involve the adaptive immune system or peripheral organs, but is rather due to the phylogenetically much older innate immune system, which appears to operate in most tissues of the body. Chronic inflammation can damage host tissue and the brain may be particularly vulnerable because of the postmitotic nature of neurons. Many of the inflammatory mediators have been shown to be locally produced and selectively elevated in affected regions of Alzheimer's brain. Moreover, studies of tissue in such degenerative processes as atherosclerosis and infarcted heart suggest a similar local innate immune reaction may be important in such conditions. Much epidemiological and limited clinical evidence suggests that nonsteroidal anti-inflammatory drugs may impede the onset and slow the progression of Alzheimer's disease. But these drugs strike at the periphery of the inflammatory reaction. Much better results might be obtained if drugs were found that could inhibit the activation of microglia or the complement system in brain, and combinations of drugs aimed at different inflammatory targets might be much more effective than single agents.</description><identifier>ISSN: 1355-0284</identifier><identifier>EISSN: 1538-2443</identifier><identifier>DOI: 10.1080/13550280290100969</identifier><identifier>PMID: 12476347</identifier><language>eng</language><publisher>United States: Informa UK Ltd</publisher><subject>Alzheimer Disease - immunology ; Disease Progression ; Encephalitis - immunology ; Humans ; Neuroimmunomodulation - immunology</subject><ispartof>Journal of neurovirology, 2002-12, Vol.8 (6), p.529-538</ispartof><rights>2002 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-9e43208929270d6335ce9ac1fd608e2235509d59c6b098a01a081c4b265c1b4c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/13550280290100969$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/13550280290100969$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,61221,61402</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12476347$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McGeer, Patrick L</creatorcontrib><creatorcontrib>McGeer, Edith G</creatorcontrib><title>Local Neuroinflammation and the Progression of Alzheimer's Disease</title><title>Journal of neurovirology</title><addtitle>J Neurovirol</addtitle><description>Postmortem immunohistochemical studies have revealed a state of chronic inflammation limited to lesioned areas of brain in Alzheimer's disease. Some key actors in this inflammation are activated microglia (brain macrophages), proteins of the classical complement cascade, the pentraxins, cytokines, and chemokines. The inflammation does not involve the adaptive immune system or peripheral organs, but is rather due to the phylogenetically much older innate immune system, which appears to operate in most tissues of the body. Chronic inflammation can damage host tissue and the brain may be particularly vulnerable because of the postmitotic nature of neurons. Many of the inflammatory mediators have been shown to be locally produced and selectively elevated in affected regions of Alzheimer's brain. Moreover, studies of tissue in such degenerative processes as atherosclerosis and infarcted heart suggest a similar local innate immune reaction may be important in such conditions. Much epidemiological and limited clinical evidence suggests that nonsteroidal anti-inflammatory drugs may impede the onset and slow the progression of Alzheimer's disease. But these drugs strike at the periphery of the inflammatory reaction. Much better results might be obtained if drugs were found that could inhibit the activation of microglia or the complement system in brain, and combinations of drugs aimed at different inflammatory targets might be much more effective than single agents.</description><subject>Alzheimer Disease - immunology</subject><subject>Disease Progression</subject><subject>Encephalitis - immunology</subject><subject>Humans</subject><subject>Neuroimmunomodulation - immunology</subject><issn>1355-0284</issn><issn>1538-2443</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1PwzAQhi0EolD4ASwoE0yB80ccW0ylfEoVMMAcOc6FpEriYicD_HpStRIDEkx3unvule4h5ITCBQUFl5QnCTAFTAMF0FLvkAOacBUzIfju2I_7eATEhByGsASgXDK1TyaUiVRykR6Q64WzpomecPCu7srGtK3pa9dFpiuivsLoxbt3jyGsZ66MZs1XhXWL_jxEN3VAE_CI7JWmCXi8rVPydnf7On-IF8_3j_PZIraC8T7WKDgDpZlmKRSS88SiNpaWhQSFjK1_0UWircxBKwPUgKJW5EwmlubC8ik52-SuvPsYMPRZWweLTWM6dEPIUpZKRXX6L0iVTCRlcgTpBrTeheCxzFa-bo3_zChka8PZL8Pjzek2fMhbLH4utkpH4GoDjDqdb02FpukrazxmSzf4blT0R_w35WmGdA</recordid><startdate>20021201</startdate><enddate>20021201</enddate><creator>McGeer, Patrick L</creator><creator>McGeer, Edith G</creator><general>Informa UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20021201</creationdate><title>Local Neuroinflammation and the Progression of Alzheimer's Disease</title><author>McGeer, Patrick L ; McGeer, Edith G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-9e43208929270d6335ce9ac1fd608e2235509d59c6b098a01a081c4b265c1b4c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Alzheimer Disease - immunology</topic><topic>Disease Progression</topic><topic>Encephalitis - immunology</topic><topic>Humans</topic><topic>Neuroimmunomodulation - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McGeer, Patrick L</creatorcontrib><creatorcontrib>McGeer, Edith G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurovirology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McGeer, Patrick L</au><au>McGeer, Edith G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Local Neuroinflammation and the Progression of Alzheimer's Disease</atitle><jtitle>Journal of neurovirology</jtitle><addtitle>J Neurovirol</addtitle><date>2002-12-01</date><risdate>2002</risdate><volume>8</volume><issue>6</issue><spage>529</spage><epage>538</epage><pages>529-538</pages><issn>1355-0284</issn><eissn>1538-2443</eissn><abstract>Postmortem immunohistochemical studies have revealed a state of chronic inflammation limited to lesioned areas of brain in Alzheimer's disease. Some key actors in this inflammation are activated microglia (brain macrophages), proteins of the classical complement cascade, the pentraxins, cytokines, and chemokines. The inflammation does not involve the adaptive immune system or peripheral organs, but is rather due to the phylogenetically much older innate immune system, which appears to operate in most tissues of the body. Chronic inflammation can damage host tissue and the brain may be particularly vulnerable because of the postmitotic nature of neurons. Many of the inflammatory mediators have been shown to be locally produced and selectively elevated in affected regions of Alzheimer's brain. Moreover, studies of tissue in such degenerative processes as atherosclerosis and infarcted heart suggest a similar local innate immune reaction may be important in such conditions. Much epidemiological and limited clinical evidence suggests that nonsteroidal anti-inflammatory drugs may impede the onset and slow the progression of Alzheimer's disease. But these drugs strike at the periphery of the inflammatory reaction. Much better results might be obtained if drugs were found that could inhibit the activation of microglia or the complement system in brain, and combinations of drugs aimed at different inflammatory targets might be much more effective than single agents.</abstract><cop>United States</cop><pub>Informa UK Ltd</pub><pmid>12476347</pmid><doi>10.1080/13550280290100969</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1355-0284
ispartof Journal of neurovirology, 2002-12, Vol.8 (6), p.529-538
issn 1355-0284
1538-2443
language eng
recordid cdi_proquest_miscellaneous_72768197
source MEDLINE; Access via Taylor & Francis; SpringerLink Journals - AutoHoldings
subjects Alzheimer Disease - immunology
Disease Progression
Encephalitis - immunology
Humans
Neuroimmunomodulation - immunology
title Local Neuroinflammation and the Progression of Alzheimer's Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T12%3A50%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Local%20Neuroinflammation%20and%20the%20Progression%20of%20Alzheimer's%20Disease&rft.jtitle=Journal%20of%20neurovirology&rft.au=McGeer,%20Patrick%20L&rft.date=2002-12-01&rft.volume=8&rft.issue=6&rft.spage=529&rft.epage=538&rft.pages=529-538&rft.issn=1355-0284&rft.eissn=1538-2443&rft_id=info:doi/10.1080/13550280290100969&rft_dat=%3Cproquest_cross%3E18656126%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18656126&rft_id=info:pmid/12476347&rfr_iscdi=true